Reuters logo
in 3 years
BRIEF-Bayer says receives EU approval for Nexavar for differentiated thyroid cancer
May 30, 2014 / 6:07 AM / in 3 years

BRIEF-Bayer says receives EU approval for Nexavar for differentiated thyroid cancer

FRANKFURT, May 30 (Reuters) - Bayer AG : * Says receives EU approval for nexavar (sorafenib) for the treatm ent of

differentiated thyroid cancer

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below